PACS

Consensus

Buy4.00 / 55 ratings · Strong Buy 0 · Buy 5 · Hold 0 · Sell 0 · Strong Sell 0
Avg target $55.50+28.5%Median $56.00High $62.00Low $48.004 targets in the last 12 months

Price vs average target

Revenue and EPS estimates

ReportedConsensus estimates
Fiscal periodFY2024Dec '24FY2025Dec '25FY2026Dec '26FY2027Dec '27FY2028Dec '28
Revenue (B)3.965.115.846.507.07
Growth YoY–+29.3%+14.3%+11.2%+8.8%
High estimate––6.146.517.71
Low estimate––5.696.326.60
Analysts––445
EPS, adjusted1.001.742.442.702.95
Growth YoY–+72.8%+40.7%+10.4%+9.3%
High estimate––2.452.743.00
Low estimate––2.422.642.91
Analysts––333

Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.

Brokers

5 firms active in the last 12 months
FirmAnalystRatingPrev ratingTargetPrev targetChgUpsideDate
JP Morgan–OverweightOverweight––––Sep 4
Truist FinancialDavid MacDonaldBuy · Aug 2026Buy$62.00$52.00+19%+44%Sep 2
OppenheimerMichael WiederhornOutperformOutperform$48.00$40.00+20%+11%Aug 10
RBC CapitalBen HendrixOutperformOutperform$52.00$47.00+11%+20%Aug 6
UBS–BuyBuy$60.00$57.00+5%+39%Aug 6

Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.